Wall Street Hits Record High For Third Straight Day
Wall Street's major indices hit record highs for the third day in a row on Friday as the post-election rally got a lift from healthcare and technology stocks.
The "Trump rally" has been roaring ahead since the November 8 vote on bets that US President-elect Donald Trump's policies will boost economic growth and inflation.
The small cap Russell 2000 and the Dow Transport indexes also hit record intraday highs.
With the rally about to enter its second month, valuations may come under focus.
The S&P 500 is currently trading at about 17.5 times forward 12-month earnings, above the 10-year median of nearly 15 times, according to Thomson Reuters StarMine.
"I think if you are a short-term trader, you may be looking to take profits and you are starting to see a little bit of that in financials," said Robert Pavlik, chief market strategist at Boston Private Wealth.
The resilience of the stock market will be put to test after the Federal Reserve's policy meeting next week, where traders expect a 94 percent chance of an interest rate increase.
At 1608 GMT (9:38 p.m. in India), the Dow Jones Industrial Average was up 40.95 points, or 0.21 per cent, at 19,655.76, after hitting 19,671.84. This is the 11th all-time high for the index since the election.
The S&P 500 was up 6.09 points, or 0.27 per cent, at 2,252.28, slightly below its high of 2,255.06.
The Nasdaq Composite was up 27.09 points, or 0.5 per cent, at 5,444.44, after hitting a high of 5,450.16
Six of the 11 major S&P 500 sectors were higher, led by a 1.03 per cent rise in health stocks and a 0.5 per cent rise in technology.
Pfizer rose 2.68 per cent and Merck 1.7 per cent, giving the biggest boost the healthcare index.
Other pharma stocks helping the index were Bristol-Myers, which rose 3 per cent after raising its quarterly dividend; and Biogen, which gained 4.1 per cent following positive data on its Alzheimer's drug.
Financials, which have been the best performers in the rally, were off 0.25 per cent.
Broadcom was the top percentage gainer on the S&P, rising 5.3 per cent after the chipmaker reported upbeat fourth-quarter results and doubled its dividend.
Coca-Cola rose 2.6 per cent and was among the top stocks on the Dow after the company said Muhtar Kent would step down as chief executive and named chief operating officer James Quincey as his successor.
Advancing issues outnumbered decliners on the NYSE by 1,427 to 1,361. On the Nasdaq, 1,682 issues rose and 1,015 fell.
The S&P 500 index showed 45 new 52-week highs and no new lows, while the Nasdaq recorded 288 new highs and five new lows.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.